Cristian Nicolae Chirila

Dr. Cristian Nicolae Chirila


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2023 in Children
Verified
Journal Article
Open access
PDF file
Cristian Nicolae ChirilaCristian Nicolae Chirila
Cristian Nicolae Chirila
CMClaudiu Mărginean
Claudiu Mărginean
PCPaula Maria Chirilă
Paula Maria Chirilă
MGMirela Liana Gliga
Mirela Liana Gliga
Regarding the hypertensive disorders of pregnancy, pre-eclampsia (PE) remains one of the leading causes of severe and life-threatening maternal and fetal complications. Screening of early-onset PE ( 38 showed 66.2% sensitivity and 83.1% specificity in predicting the occurrence of PE within 4 weeks. Furthermore, 2018 ISUOG Practice Guidelines stated that a second-trimester mean uterine artery PI ≥ 1.44 increases the risk of later PE development. The implementation of a standard screening procedure based on the sFlt-1/PlGF ratio and uterine Doppler velocimetry may improve early detection of pre-eclampsia and other placenta-related disorders.

14 April 2024 in Children
Verified
Journal Article
Open access
PDF file
Cristian Nicolae ChirilaCristian Nicolae Chirila
Cristian Nicolae Chirila
MCMărginean Claudiu
Mărginean Claudiu
DGDana Ghiga
Dana Ghiga
SVSeptimiu Voidăzan
Septimiu Voidăzan
PCPaula Maria Chirilă
Paula Maria Chirilă
MGMirela Liana Gliga
Mirela Liana Gliga
Hypertensive disorders of pregnancy (HDPs) represent a significant source of severe maternal and fetal morbidity. Screening strategies relying on traditional medical history and clinical risk factors have traditionally shown relatively modest performance, mainly in the prediction of preeclampsia, displaying a sensitivity of 37% for the early-onset form and 29% for the late-onset form. The development of more accurate predictive and diagnostic models of preeclampsia in the early stages of pregnancy represents a matter of high priority. The aim of the present paper is to create an effective second trimester prediction algorithm of early-onset HDP occurrence and severity, by combining the following two biochemical markers: a soluble fms-like tyrosine kinase 1 (sFlt-1)/placental growth factor (PlGF) ratio and uterine artery Doppler ultrasound parameters, namely the pulsatility index (PI) and the resistivity index (RI), in a population of high-risk pregnant women, initially assessed through traditional risk factors. A prospective single-center observational longitudinal study was conducted, in which 100 women with singleton pregnancy and traditional clinical and medical history risk factors for preeclampsia were enrolled at 24 weeks of gestation. Shortly after study enrollment, all women had their sFlt-1 and PlGF levels and mean uterine artery PI and RI determined. All pregnancies were followed up until delivery. Receiver operating characteristic (ROC) analysis established algorithms based on cutoffs for the prediction of the later development of preeclampsia: PI 1.25 (96.15% sensitivity, 86.49% specificity), RI 0.62 (84.6% sensitivity, 89.2% specificity) and sFlt-1/PlGF ratio 59.55 (100% sensitivity, 89.2% specificity). The sFlt-1/PlGF ratio was the best predictor for preeclampsia, as it displayed the highest area under the curve (AUC) of 0.973. The prediction algorithm for the severe form of preeclampsia, complicated by fetal growth restriction leading to preterm birth, antepartum fetal demise or acute fetal distress with a cerebro-placental ratio of <one consisted of the following cutoffs: PI 1.44 (93.75% sensitivity, 95.24% specificity), RI 0.69 (87.5% sensitivity, 100% specificity) and sFlt-1/PlGF ratio 102.74 (93.75% sensitivity, 95.2% specificity). These algorithms may significantly enhance the prediction accuracy of preeclampsia compared to traditional risk factors. The combination of the sFlt-1/PlGF ratio with mean uterine PI and RI in particular displayed an improved performance in the prediction of severe preeclampsia with the above-mentioned complications, compared to the biochemical markers or uterine Doppler parameters used alone. Therefore, HDP screening strategies should increasingly focus on implementing such algorithms for women who are initially regarded as high risk based on traditional risk factors, in order to properly diagnose HDP and properly limit or manage the later maternal and fetal complications.

14 April 2023 in Ultrasonic Imaging
Verified
Journal Article
Closed access
MGMirela Liana Gliga
Mirela Liana Gliga
Cristian Nicolae ChirilaCristian Nicolae Chirila
Cristian Nicolae Chirila
PCPaula Maria Chirila
Paula Maria Chirila
Our paper presents the ultrasound (US) patterns of a rare kidney disease—medullary sponge kidney (MSK)—that have not been described before in comparison with other causes of medullary hyperechogenicity and correlates them with the severity of the disease and prognosis. This is a clinical observational study of all US examinations in the Nephrology Department over a period of 6 years. The abdominal US focused on the kidneys was recorded. US characteristics of the medulla and cortex were analyzed. We found 10 patients with characteristic daisy flower (DF) kidneys. Positive diagnosis in association with other renal risk factors, prognosis, and evolution were evaluated. Two patterns of medullary hyperechogenicity were found and were correlated with disease severity and kidney function. The first pattern is a homogenous echogenicity of the medulla described as a “daisy-like” appearance. The second pattern: calcifications associated with medullar echogenicity, stone production, nephrocalcinosis, and impaired kidney function: “atypical daisy-like.” Medullary hyperechogenicity can have more US patterns. In MSK, if the medullary echogenicity is homogenous the evolution is benign, whereas the second, inhomogeneous pattern, has a variable clinical presentation with nephrocalcinosis and the outcome is more severe, leading to chronic kidney disease and impairing the quality of life.

20 June 2022 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
Cristian Nicolae ChirilaCristian Nicolae Chirila
Cristian Nicolae Chirila
PCPaula Maria Chirila
Paula Maria Chirila
AGAdriana Gomotirceanu
Adriana Gomotirceanu
MGMihail Gliga
Mihail Gliga
MGMirela Liana Gliga
Mirela Liana Gliga

20 June 2022 in Ultrasound in Medicine & Biology
Verified
Journal Article
Closed access
VBVirginia Bodescu
Virginia Bodescu
SVSanda Lucia Voicu
Sanda Lucia Voicu
CRCristina Rusu
Cristina Rusu
AGAdriana Gomotarceanu
Adriana Gomotarceanu
MGMirela Liana Gliga
Mirela Liana Gliga
Cristian Nicolae ChirilaCristian Nicolae Chirila
Cristian Nicolae Chirila